NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
Back to search
Official data from USPTO
ALZAMEND NEURO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ALZAMEND NEURO
ST13
US500000097977458Class
42
Filing
97977458
Registration
7327470
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
03/12/2024
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
06/29/2022
Registration date
03/12/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2024
Last transaction
03/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/08/2021
First use in commerce
11/08/2021
Drawing code
4
Owner type
03
Owner location
Atlanta, GA, US
Examiner
SMITH, REBECCA A
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Alzamend Neuro, Inc.
Representatives
DAVID R. CONKLIN KIRTON MCCONKIE
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical, biologic and immunological research and development; pharmaceutical, biologic and immunological product development; pharmaceutical, biologic and immunological drug and vaccine development services
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
02/06/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
02/06/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/05/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/25/2024
DRRR
DIVISIONAL REQUEST RECEIVED
01/25/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/25/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/13/2024
EX1G
SOU EXTENSION 1 GRANTED
01/11/2024
EXT1
SOU EXTENSION 1 FILED
01/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/11/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2023
PUBO
PUBLISHED FOR OPPOSITION
05/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2023
DOCK
ASSIGNED TO EXAMINER
04/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2022
NWAP
NEW APPLICATION ENTERED
07/02/2022
Continuous trademark protection
Get notified about every new filing that threatens ALZAMEND NEURO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.